Publications by authors named "Leo Bon"

Claim this Profile
E
Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases.
Inês Dias, Leo Bon, Angelika Banas, Daniel Chavarria, Fernanda Borges

J Inorg Biochem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease.
Leo Bon, Angelika Banaś, Inês Dias, Inês Melo-Marques, Sandra M Cardoso

Pharmaceutics· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis